Debut Engineers New Biotech Ingredient for Hyperpigmentation

Summary

Debut announced a new biotech-derived active ingredient for hyperpigmentation correction and skin brightening, demonstrating clinical efficacy at 0.45% concentration, which is less than half the EU's maximum allowed level for kojic acid in face and hand products.